A detailed history of Vanguard Group Inc transactions in Exicure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 40,093 shares of XCUR stock, worth $118,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,093
Previous 40,093 -0.0%
Holding current value
$118,675
Previous $24,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.37 - $0.75 $1,840 - $3,731
4,975 Added 14.17%
40,093 $23,000
Q3 2023

Nov 14, 2023

BUY
$0.71 - $1.36 $568 - $1,088
800 Added 2.33%
35,118 $25,000
Q1 2023

May 15, 2023

SELL
$0.78 - $1.58 $393 - $796
-504 Reduced 1.45%
34,318 $29,000
Q3 2022

Nov 14, 2022

SELL
$1.53 - $8.5 $85,126 - $472,923
-55,638 Reduced 61.51%
34,822 $55,000
Q2 2022

Aug 12, 2022

BUY
$2.16 - $6.36 $195,393 - $575,325
90,460 New
90,460 $195,000

Others Institutions Holding XCUR

About EXICURE, INC.


  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $14.7M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.